|
27 Mar 2007 |
Novartis to launch its own branded version of a leading multiple sclerosis therapy through agreement with Bayer Schering Pharma
|
|
27 Mar 2007 |
Cephalon, Inc. (CEPH) Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
|
|
24 Mar 2007 |
NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
|
|
23 Mar 2007 |
Topigen and Novagali enter into strategic collaboration for allergic ocular diseases and allergic rhinitis
|
|
23 Mar 2007 |
Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder
|
|
23 Mar 2007 |
Cubist Pharmaceuticals Licenses Rights for Development and Commercialization of CUBICIN in Japan to Merck & Co., Inc.
|
|
23 Mar 2007 |
MilleGen and LFB Sign Research Partnership Agreement to Develop New Generation of Therapeutic Monoclonal Antibodies
|
|
23 Mar 2007 |
VASTox plc Acquires DanioLabs Ltd and Dextra Laboratories Ltd to Strengthen Its Drug Discovery Pipeline and Pharmaceutical Services Business
|
|
22 Mar 2007 |
Fralex Therapeutics Inc. initiates pivotal trial for chronic pain associated with fibromyalgia
|
|
22 Mar 2007 |
BioLineRx In-Licenses Novel Peptide for the Treatment of Inflammatory Diseases
|
|
22 Mar 2007 |
Medtronic Announces Strategic Agreement with Osteogenix, Incorporated
|
|
22 Mar 2007 |
Synovics Pharmaceuticals Files ANDA for Generic Hydroxyzine
|
|
22 Mar 2007 |
Eisai's Dramatic Leap towards Biologic Therapeutics Evidenced by the Acquisition
|
|
21 Mar 2007 |
Abraxis BioScience to Initiate Two Phase I/II Clinical Trials with nab-docetaxel in Hormone Refractory Prostate and Metastatic Breast Cancer
|
|
21 Mar 2007 |
Wockhardt to market painkiller in the US, Sixteenth US FDA-approved product
|
|
21 Mar 2007 |
GenVec Signs Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NIAID) to Develop RSV Vaccines
|
|
21 Mar 2007 |
Dharma Therapeutic Shows IDDS is Effective in Reducing Pain Associated with Insertion of an Intravenous Catheter in their Phase 2 Clinical Trial
|
|
21 Mar 2007 |
Cannasat Therapeutics and IntelGenx Enter Into Agreement to Develop Cannabinoid-Based Products for the Treatment of Mood Disorders Such as Anxiety and Depression
|
|
20 Mar 2007 |
Miraculins announces positive results in pivotal prostate cancer biomarker study
|
|
20 Mar 2007 |
Akesis Pharmaceuticals Obtains Exclusive License for Proprietary Clinical Stage Diabetes Therapy from the University of British Columbia
|
|
20 Mar 2007 |
Evotec and Boehringer Ingelheim Enter into Target Discovery Collaboration in Alzheimer's Disease
|
|
20 Mar 2007 |
Angiotech Initiates U.S. Pivotal Trial for the Vascular Wrap Paclitaxel-Eluting Mesh
|
|
17 Mar 2007 |
Micromet and TRACON Pharmaceuticals Sign Exclusive Worldwide License Agreement to Develop and Commercialize D93, a Humanized Antibody for Cancer Treatment
|
|
17 Mar 2007 |
Genmab in Research Cooperation with the Dahanca-Group
|
|
17 Mar 2007 |
Nippon Shinyaku and Teva terminate HMN-214 License Agreement
|
